Project Grant R21AI200399
- Federal Project Grant Award Summary Cornell University's Office of Sponsored Programs received a $743,943 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 5, 2026, through April 30, 2031. This research initiative focuses on advancing the understanding and engineering of antimicrobial peptides (AMPs) as potential therapeutic compounds to combat opportunistic...
- Federal Grant Award Summary Cornell University received a $219,852 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 1, 2026 through April 28, 2028. This exploratory research initiative investigates the bacterial endosymbiont accommodation (BEA) program in early-divergent mucoromycete fungi, with the objective of elucidating the developmental and regulatory...
- Federal Grant Award Summary Cornell University, through its Office of Sponsored Programs, received a $591,368 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 11, 2025, with a completion date of July 31, 2030. The award supports fundamental research aimed at understanding the epigenetic regulation of natural killer (NK) cell memory, with particular focus on...
- Federal Grant Award Summary Cornell University's Office of Sponsored Programs received a Project Grant of $238,810 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on September 1, 2025, with completion scheduled for August 31, 2027. The research project, titled "Embryonic Origins of T Cells," addresses fundamental gaps in understanding T lymphocyte development and function. The grant...
- Federal Project Grant Award Summary Cornell University received a $247,362 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 8, 2025, through August 31, 2027. The award funds research aimed at developing a novel framework to characterize Aedes aegypti mosquito population structure and dispersal patterns across multiple spatial scales to inform targeted arbovirus...
- Federal Grant Award Summary Cornell University's Office of Sponsored Programs received a $2.8 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 4, 2026, with a completion date of January 31, 2030. This research grant supports biomedical investigation into post-transcriptional regulation mechanisms controlling pathogenic T helper 17 (Th17) cell function, with...
- Federal Grant Award Summary Cornell University's Office of Sponsored Programs received a $392,714 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025 through July 31, 2030. The award supports research and development of lipid nanoparticles (LNPs) designed to enhance endosomal escape and reduce reactogenicity—key barriers to effective nucleic acid-lipid...
- Federal Project Grant Award Summary Cornell University's Office of Sponsored Programs received a $746,602 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025 through July 31, 2030. The award supports investigator-initiated biomedical research to develop novel therapeutics for tuberculosis (TB) treatment by stimulating bacterial cyclic adenosine monophosphate...
- Federal Project Grant Award Summary Weill Medical College of Cornell University received a $1.67 million Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 11, 2025, with a completion date of May 31, 2030. The award funds research investigating the molecular mechanisms by which Enterococcus faecalis transitions from a benign commensal bacterium to a pathogenic organism capable of...
- Federal Grant Award Summary Cornell University's Office of Sponsored Programs received a $408,133 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded May 7, 2026, with completion scheduled for April 30, 2031. The project, "A Systems Approach to Understanding Beta Lactam Antibiotic Mechanism of Action," will deliver comprehensive research services and scientific findings to...
Cornell University received a $196,250 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 6, 2026, with a completion date of April 30, 2028. The award supports research into hierarchical gene regulatory networks controlled by the hormone 20-hydroxyecdysone in the fruit fly model organism Drosophila melanogaster. The research deliverables include transcriptomic profiling, computational analysis of gene regulation, and direct assays of DNA-binding patterns to distinguish primary-level hormone-regulated genes from secondary-level genes regulated by transcription factors. This integrated approach addresses the current scientific limitation of relying solely on transcriptomic data to understand how pleiotropic hormones regulate distinct physiological processes. The project focuses on deciphering 20-hydroxyecdysone's role in both developmental processes and immune system regulation through an ex vivo tissue assay to construct the complete gene-regulatory network and experimental bacterial infections to validate findings in an immunological context. Outcomes of this research will advance understanding of how modest differences at the primary regulatory level can generate larger, functionally specialized differences at secondary regulatory levels, with potential applications to understanding hormone-mediated trade-offs in immune function and development across biological systems.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $196.3k | 5/7/26 |